Peginterferon for chronic hepatitis B: Predicting success with on-treatment benchmarks

被引：7
作者：
Moucari, Rami [1 ,2 ]
机构：
[1] Hop Beaujon, Serv Hepatol, F-92110 Clichy, France
[2] Hop Beaujon, INSERM, U773, F-92110 Clichy, France
来源：
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 2010年 / 25卷 / 09期
关键词：
SUSTAINED HBEAG; SERUM HBSAG; INTERFERON; SEROCONVERSION; SUPPRESSION; ALPHA-2A; THERAPY;
D O I：
10.1111/j.1440-1746.2010.06372.x
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1474 / 1475
页数：2
相关论文
共 50 条
  • [41] HEPATITIS Treatment failure in chronic hepatitis B
    Zoulim, Fabien
    NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2011, 8 (07) : 366 - 367
  • [42] Clinical characteristics of chronic hepatitis B cured by peginterferon in combination with nucleotide analogs
    Bao, Xuli
    Guo, Jia
    Xiong, Fang
    Qu, Yachao
    Gao, Yao
    Gu, Na
    Lu, Jun
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2020, 96 : 562 - 566
  • [43] Expression Pattern of Cytokines in Patients with Chronic Hepatitis B Receiving PEGinterferon Therapy
    Chen, Shao-Long
    Xiao, Hong
    Li, Guo-Jun
    Shen, Yao-Jie
    INTERNATIONAL JOURNAL OF GENERAL MEDICINE, 2023, 16 : 1771 - 1782
  • [44] A baseline model including quantitative anti-HBc to predict response of peginterferon in HBeAg-positive chronic hepatitis B patients
    Fang, Yu-Qing
    Xu, Xiao-Yan
    Hou, Feng-Qin
    Jia, Wei
    ANTIVIRAL THERAPY, 2021, 26 (6-8) : 126 - 133
  • [45] Serum HBsAg Levels During Peginterferon α-2a Treatment With or Without Thymosin α-1 in HBeAg-Positive Chronic Hepatitis B Patients
    Song, Eun Young
    Shin, Yunsu
    Roh, Eun Youn
    Sue, Shin
    Park, Myoung Hee
    Kim, Bo Hyun
    Kim, Won
    Yoon, Jung-Hwan
    Lee, Youn-Jae
    Park, Sung Jae
    Jung, Eun Uk
    Lee, Jeong-Hoon
    Myung, Sun Jung
    Kim, Yoon-Jun
    Lee, Hyo-Suk
    JOURNAL OF MEDICAL VIROLOGY, 2011, 83 (01) : 88 - 94
  • [46] Role of interleukin-21 and interleukin-21 receptor polymorphisms in the treatment of HBeAg-positive chronic hepatitis B patients with peginterferon
    Wang, Xia
    Xu, Zhi-Qiang
    Fu, Juan-Juan
    Cheng, Li-Wei
    Li, Yan
    Li, Li
    Pan, Xiu-Cheng
    MEDICINE, 2018, 97 (23)
  • [47] Serum proteins in chronic hepatitis B patients treated with peginterferon alfa-2b
    Kuakarn, Sunida
    SomParn, Poorichaya
    Tangkijvanich, Pisit
    Mahachai, Varocha
    Thongboonkerd, Visith
    Hirankarn, Nattiya
    WORLD JOURNAL OF GASTROENTEROLOGY, 2013, 19 (31) : 5067 - 5075
  • [48] Extended duration versus standard duration of peginterferon alfa-2a in treatment of chronic hepatitis B: A systematic review and meta-analysis
    Wang, Zhengyan
    Sun, Ling
    Wu, Yuwan
    Xia, Qing
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2016, 40 (02) : 195 - 202
  • [49] Prediction model for sustained hepatitis B e antigen seroconversion to peginterferon alfa-2a in chronic hepatitis B
    Zhu, Huilan
    Wang, Changtai
    Zhang, Yafei
    Wei, Shaofeng
    Li, Xu
    Zhang, Zhenhua
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2016, 31 (12) : 1963 - 1970
  • [50] Tongue Hyperpigmentation Resulting from Peginterferon Alfa-2b and Ribavirin Treatment in a Patient with Chronic Hepatitis C
    Ghosh, Souvik
    Duseja, Ajay
    Dhiman, Radha Krishan
    Chawla, Yogesh Kumar
    DIGESTIVE DISEASES AND SCIENCES, 2012, 57 (03) : 820 - 821
12345